Intraepithelial lymphocytes (IEL) of the small intestine are in intimlte contact with the enormous antigenic load of the intestinal lumen and constitute one of the largest lymphocyte populations in the body.' Furthermore, an increased proportion of IEL is found in the enteropathies of coeliac disease and cow's milk protein intolerance as well as in certain parasitic infections.' Although these features suggest an important role for IEL in vivo, the mechanisms by which IEL contribute to local defence, or to the pathogenesis of enteropathies are not yet clear.
In mnost species, the majority of IEL appear to be T cells and have the phenotype of suppressor/cytotoxic cells."' Furthermore IEL from experimental animals can mediate both specific and non-specific cell mediated cytotoxicity in vitro.""`Nevertheless, many of the conditions characterised by an increased proportion of IEL appear to be mediated by proliferative, rather than cytotoxic T lymphocytes. '4 Therefore, it is important to investigate the potential ability of IEL to exhibit proliferative T cell functions. As there is controversy over the ability of IEL to proliferate in response to T cell mitogens or alloantigens in vitro,''" we have studied the proliferative responses of IEL using an in vivo approach.
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The validity of this approach is supported by the fact that murine IEL can transfer a local DTH reaction in vivol7 and can mediate a local graftversus-host (GvHR) in the popliteal lymph node of intact hosts.`"XA paradoxical finding from our previous work, however, was that intravenously injected IEL failed to induce a systemic GvHR in irradiated hosts. As these studies also showed that IEL required adherent accessory cells and lymphoid cell products to proliferate in vitro,'6 one reason for their inability to induce a systemic GvHR in irradiated mice could be because accessory factors were absent from the irradiated hosts. Alternatively, as the recirculation pathways of IEL have not been studied, their failure to induce systemic GvHR could reflect an inability to enter lymphoid tissues and encounter host alloantigens.
Baca, Mowat, A\lack7Iic, nd P(arrgott purified as described previously.' Briefly, the small intestine was removed into cold calcium magnesium free Hanks' balanced salt solution (CMF) (Gibco) and washed through with 2(0 ml fresh CMF. The Peyer's patches were then remloved, the intestine slit longitudinally and divided into pieces [2] [3] 2x 10" lymphocytes in RPMI + 5(YONCS + 100 Ft/ml penicillin+ 1()() g/ml streptomycin (Gibco) were layered onto fresh collagen matrices and incubiated at 370 overnight, before fixation with 2-5'Y0 glutaraldehyde in RPMI for 30 miniutes.
The proportion of cells inviading the gel was assessed by counting the cells at 10 tm intervals through the gel at x20)0 magnification using a Nikon phase conitrast inverted microscope.
STATIS'I'ICAI, ANALYSIS
Groups of menans and standard deviiations were compiared by Student's i-test, while survival after irradiation was expressed as median survival times (MST), and the mortality curves were compared using Wilcoxon's Rank sum test. As before, all lethally irradiated (CBAx BALB/c)F, mice were given 107 CBA spleen cells died within six to eight days, with characteristic features of GvHR (Fig. 2) . Daily administration of IOOOU rIL-2 did not alter this highly aggressive form of GvHR. In this experiment, insufficient IEL were available to transfer alone to F, hosts, but it was clear that mice receiving IEL plus daily injection of rIL-2 had a survival pattern which was identical to irradiated mice given rIL-2 alone. In addition, mice given IEL+rIL-2 had no clinical evidence of GvHR and survived significantly longer than spleen cell recipients. That the schedule of rIL-2 dosage used had a biological effect in recipients was confirmed by the fact that mice receiving rIL-2 alone died more rapidly than unreconstituted, irradiated controls (Fig. 2) 3 and 4). Two hours after injection, spleen cells were found predominantly in the lungs, spleen and liver, although a small, but consistent proportion were already present in the gut and lymph nodes at this time (Fig. 3) . By 18 hours, less labelled cells were found in the blood and lungs and there was now a significant accumulation of cells in the lymph nodes (Fig. 4) . The recovery of label from gut, spleen, liver, and kidney was similar at both time intervals.
In comparison with these findings, IEL showed a very different pattern of redistribution. Two hours after injection, the vast majority of cells were found in liver and a smaller proportion in lungs. In comparison with spieen cells, significantly fewer IEL were found in the spleen and there was virtually no accumulation in lymph nodes (Fig. 3) . In parallel a larger proportion of IEL were present in the kidneys (p<0-001) and liver (p<0-025) when compared with spleen cells. By 18 hours, there was a slight fall in the number of IEL found in the lungs, but there was no accumulation of IEL in lymph nodes (Fig. 4) (Fig. 5) .
ILOCOMOTOR ACTIVITY OF IEL IN VITRO
The presence of I EL within the most superficial layer of the gut suggests that these cells may be highly motile in sitl. Therefore, it was important to examine if the failure to migrate in vivo was because isolation of IEL rendered them incapable of all locomotor functions. This issue was addressed by comparing the ability of IEL, spleen cells and MLN to invade collagen gels the method of choice for determining lymphocyte locomotion in vitro.'' These studies showed that IEL had an excellent locomotor capacity in vitro and migrated into collagen gels as readily as MLN and much more efficiently than spleen cells (Fig. 6) (Fig. 6) .
Disscusion
We have shown in this report that the inability of IEL to mediate a systemic, lethal GvHR in irradiated hosts is not reversed by the addition of bone marrow accessory cells or IL-2. Despite an excellent capacity for locomotion in vitro, however, IEL do not migrate from blood into lymphoid tissue in vivo. Thus we suggest that the failure of IEL to induce a GvHR after intravenous injection is because of their inability to enter lymphoid tissue and encounter host alloantigens.
We had initiated in vivo studies of the induction of GvHR by IEL to mediate as a way of investigating their proliferative T cell functions which would not be to investigate whether this defect reflected a dependence of IEL on exogenous accessory cells and lymphocyte mediators in vivo, similar to that observed for proliferative responses in vitro. "
Interleukin 2, including the preparation used here, augments the response of IEL to mitogens iin vitro (Mclnnes and Mowat, unpublished observations). In addition, the ability of other T cells to induce GvtH R is enhanced by concurrent administration of IL-2 in vivo."' Bone marrow cells of both donor and host origin also increase the severity of GvHR, either by providing an additional source of donor T cells, or because of accessory cell functions such as increased presentation of host alloantigens."' In the present study, however, neither addition of BM cells nor administration of IL-2 allowed IEL to induce a GvHR in irradiated hosts. Although these findings could suggest that IEL are incapable of proliferative T cell functions in vivo, this interpretation seemed unlikely in view of the ability of IEL to induce a local GvHR in the popliteal lymph node' "' and to transfer a local DTH response.'7 In addition, under appropriate circumstances, IEL can recognise and proliferate in response to alloantigens in vitro. 5 For these reasons we considered the possibility that iv injected IEL could not induce systemic GvHR because of a failure to migrate from blood into lymphoid tissue in vivo. The recirculation pathways of IEL have not been detailed previously and we show here that IEL did not enter lymph nodes when injected intravenously. Furthermore, compared with spleen cells significantly fewer IEL entered the spleen and small intestine. In parallel, after transfer of IEL, more label accumulated in the liver and kidney and IEL showed slightly delayed clearance from the bloodstream. The high recovery of label found in the liver and kidney after transfer of I EL was not merely because of trapping and destruction of damaged cells, because injected IEL were of high viability, as shown by their efficient retention of 'Cr label and by their high motility in vitro. Furthermore, we have found that heat killed cells are rapidly eliminated after transfer and do not exhibit the same redistribution in vivo as IEL (unpublished observations). One finding of interest was that as well as their failure to migrate into peripheral lymph nodes, IEL failed to enter the intestine or its lymphoid tissues. These results contrast with suggestions that IEL may be a gut homing population in vivo and may be able to bind high endothelial venules (HEV) from Peyer's patches (PP) in vitro."4 The single report which indicated that IEL may enter PP three to four days after transfer in vivo5 used poorly defined populations of IEL(s), however, and our own recent work indicates that pure IEL do not migrate to PP or other intestinal tissues at any time from one to four days after transfer (manuscript in preparation). In addition, it has been shown that murine IEL do not possess the MEL-14 antigen which seems to mediate binding to lymph node HEV in ViV,o. 4 Together, these findings support our conclusion that IEL are essentially a non-recirculatory population of lymphoid cells.
Two aspects of our study may help understand the biological role of IEL in situ. Firstly, although a large proportion of IEL are granulated,5' their relationship to the other granulated cells, such as mast cells or natural killer (NK) cells, has been a matter of controversy.-"Therefore, it is of considerable interest that a recent study in rats has shown that highly purified peripheral blood, large granular lymphocytes with NK cell function exhibit a pattern of migration in vivo which is virtually identical to that we found for mouse IEL. Intraepithelial lymphocytes are capable of NK cell activity in vitro" '2 and together these findings suggest that at least some IEL respresent a population of granulated effector lymphocytes which are committed to cytotoxic functions in vivo. Secondly, despite their failure to recirculate in vivo, IEL were highly motile in vitto. T cell clones which have been activated in vitro by IL2 and T lymphocytes which are stimulated by antigen in vivo""' also show defective recirculation in vivo. Furthermore, activated cells and lymphoblasts migrate into collagen gels more effectively than small lymphocytes."2 These features support the concept that IEL may already be activated in sitlu. Therefore, our study indicates that IEL may be particularly important in protecting the intestinal mucosa because many of these cells are already activated or rapidly become so after their arrival in the epithelium. Further studies of the migratory properties of IEL subpopulations in vivo and in vitro are in progress to establish which subset(s) of this heterogenous population normally show these characteristics. 
